Page 31 - காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioNTech SE Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 vaccine bringing total doses for U.S. to 200 million All 200 million doses will be produced by U.S. manufacturing facilities and are expected to be delivered by July 31, 2021, allowing for 100 million people in the U.S. to be vaccinated NEW YORK and MAINZ, GERMANY, December 23, 2020 (GLOBE NEWSWIRE) BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (

United statesAlex azarSylke maasAlbert bourlaChuck trianoAmy roseUgur sahinFosun pharmaUs centers for diseaseDrug administrationAdvisory committee on immunization practicesBayer animal healthExchange commissionAdministration errorsPfizer incRoche group